Cargando…
Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States with no effective treatment. The current diagnostic method, spirometry, does not accurately reflect the severity of COPD disease status. Therefore, there is a pressing unmet medical need...
Autores principales: | Liu, Ding, Meister, Maureen, Zhang, Shiying, Vong, Chi-In, Wang, Shuaishuai, Fang, Ruixie, Li, Lei, Wang, Peng George, Massion, Pierre, Ji, Xiangming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507726/ https://www.ncbi.nlm.nih.gov/pubmed/32957957 http://dx.doi.org/10.1186/s12931-020-01507-9 |
Ejemplares similares
-
Tocotrienols: Dietary Supplements for Chronic Obstructive Pulmonary Disease
por: Ji, Xiangming, et al.
Publicado: (2021) -
Disturbance of serum lipid metabolites and potential biomarkers in the Bleomycin model of pulmonary fibrosis in young mice
por: Yang, Xiao-hui, et al.
Publicado: (2022) -
Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics
por: Yan, Feng, et al.
Publicado: (2017) -
Serum Surfactant Protein D: Biomarker of Chronic Obstructive Pulmonary Disease
por: Ju, Chun-Rong, et al.
Publicado: (2012) -
Chronic Obstructive Pulmonary Disease and Subsequent Overall and Lung Cancer Mortality in Low-Income Adults
por: Aldrich, Melinda C., et al.
Publicado: (2015)